The Cooper Companies Stock Forecast, Price & News

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for The Cooper Companies in the last twelve months. There are currently 4 hold ratings and 7 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" The Cooper Companies stock.
View analyst ratings for The Cooper Companies or view top-rated stocks.

Wall Street analysts have given The Cooper Companies a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but The Cooper Companies wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

The Cooper Companies is scheduled to release its next quarterly earnings announcement on Thursday, September 2nd 2021.
View our earnings forecast for The Cooper Companies.

The Cooper Companies, Inc. (NYSE:COO) announced its earnings results on Wednesday, June, 2nd. The medical device company reported $3.38 EPS for the quarter, beating analysts' consensus estimates of $3.09 by $0.29. The medical device company earned $719.50 million during the quarter, compared to analysts' expectations of $691.63 million. The Cooper Companies had a trailing twelve-month return on equity of 12.02% and a net margin of 88.54%. The business's revenue was up 37.1% compared to the same quarter last year. During the same quarter in the prior year, the company earned $1.51 earnings per share.
View The Cooper Companies' earnings history.

The Cooper Companies' stock was trading at $323.89 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, COO stock has increased by 15.8% and is now trading at $375.19.
View which stocks have been most impacted by COVID-19.

The Cooper Companies announced a Semi-Annual dividend on Thursday, January 7th. Shareholders of record on Friday, January 22nd will be given a dividend of $0.03 per share on Tuesday, February 9th. The ex-dividend date is Thursday, January 21st.
View The Cooper Companies' dividend history.

The Cooper Companies pays an annual dividend of $0.06 per share and currently has a dividend yield of 0.02%. The Cooper Companies does not yet have a strong track record of dividend growth. The dividend payout ratio of The Cooper Companies is 0.62%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, The Cooper Companies will have a dividend payout ratio of 0.41% next year. This indicates that The Cooper Companies will be able to sustain or increase its dividend.
View The Cooper Companies' dividend history.

The Cooper Companies issued an update on its FY 2021 earnings guidance on Tuesday, June, 8th. The company provided EPS guidance of $13.200-13.400 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $13.040. The company issued revenue guidance of $2.86 billion-2.89 billion, compared to the consensus revenue estimate of $2.83 billion.

11 brokers have issued 1-year target prices for The Cooper Companies' stock. Their forecasts range from $315.00 to $450.00. On average, they expect The Cooper Companies' stock price to reach $387.17 in the next year. This suggests a possible upside of 3.2% from the stock's current price.
View analysts' price targets for The Cooper Companies or view top-rated stocks among Wall Street analysts.

8 employees have rated The Cooper Companies CEO Robert S. Weiss on Glassdoor.com. Robert S. Weiss has an approval rating of 80% among The Cooper Companies' employees.

Some companies that are related to The Cooper Companies include Align Technology (ALGN), West Pharmaceutical Services (WST), DENTSPLY SIRONA (XRAY), STAAR Surgical (STAA), Quidel (QDEL), Neogen (NEOG), ICU Medical (ICUI), Merit Medical Systems (MMSI), Haemonetics (HAE), Atrion (ATRI), Cerus (CERS), Meridian Bioscience (VIVO), Antares Pharma (ATRS), OraSure Technologies (OSUR) and Anika Therapeutics (ANIK).
View all of COO's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other The Cooper Companies investors own include The Boeing (BA), AbbVie (ABBV), NVIDIA (NVDA), Netflix (NFLX), Johnson & Johnson (JNJ), Gilead Sciences (GILD), Intel (INTC), Alibaba Group (BABA), Intuitive Surgical (ISRG) and Mastercard (MA).

The Cooper Companies trades on the New York Stock Exchange (NYSE) under the ticker symbol "COO."

The Cooper Companies' stock is owned by many different retail and institutional investors. Top institutional shareholders include Price T Rowe Associates Inc. MD (8.07%), BlackRock Inc. (7.38%), Veritas Asset Management LLP (4.78%), Janus Henderson Group PLC (4.56%), Generation Investment Management LLP (4.40%) and Massachusetts Financial Services Co. MA (2.70%). Company insiders that own The Cooper Companies stock include Agostino Ricupati, Albert G White III, Allan E Rubenstein, Gary S Petersmeyer, Holly R Sheffield, Jody S Lindell, Michael Kalkstein, Randal Golden and Robert D Auerbach.
View institutional ownership trends for The Cooper Companies.

COO stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc., Neuberger Berman Group LLC, FIL Ltd, Generation Investment Management LLP, Putnam Investments LLC, Goldman Sachs Group Inc., Massachusetts Financial Services Co. MA, and Martingale Asset Management L P. Company insiders that have sold The Cooper Companies company stock in the last year include Agostino Ricupati, Albert G White III, Gary S Petersmeyer, Jody S Lindell, and Robert D Auerbach.
View insider buying and selling activity for The Cooper Companies or view top insider-selling stocks.

COO stock was purchased by a variety of institutional investors in the last quarter, including JPMorgan Chase & Co., Nuveen Asset Management LLC, Intermede Investment Partners Ltd, Jennison Associates LLC, Kayne Anderson Rudnick Investment Management LLC, Polar Capital Holdings Plc, Janus Henderson Group PLC, and Bank of New York Mellon Corp. Company insiders that have bought The Cooper Companies stock in the last two years include Agostino Ricupati, Albert G White III, and Holly R Sheffield.
View insider buying and selling activity for The Cooper Companies or or view top insider-buying stocks.

Shares of COO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of COO stock can currently be purchased for approximately $375.19.

The Cooper Companies has a market capitalization of $18.48 billion and generates $2.43 billion in revenue each year. The medical device company earns $238.40 million in net income (profit) each year or $9.64 on an earnings per share basis.

The Cooper Companies employs 12,000 workers across the globe.

The following companies are subsidiares of The Cooper Companies: CVI Contact Lens India Pvt. Ltd., Cooper Medical Inc., CooperSurgical, CooperSurgical Holdings Ltd., CooperVision (UK) Holdings Ltd., CooperVision Australia Pty Limited, CooperVision Canada Corp., CooperVision Caribbean Corp, CooperVision Distribution SPRL, CooperVision GmbH, CooperVision Iberia SL, CooperVision International Holding Company LP, CooperVision Italia Srl, CooperVision Japan Inc., CooperVision Ltd., CooperVision Manufacturing Costa Rica SRL, CooperVision Manufacturing Limited, CooperVision Nederland B.V. Belgian Branch, CooperVision Nederland BV, CooperVision Nordic AB, CooperVision Optical Trading (Shanghai) Company Ltd., CooperVision Sarl, CooperVision Singapore Pte Ltd., CooperVision do Brasil Ltda, Coopervision, Coopervision S.A. (Pty) Limited, Invitro Genetics Inc., ORIGIO Inc, Ocular Sciences SAS, Origio A/S, Recombine Inc., Reprogenetics LLC, Research Instruments Ltd., Sauflon CL Ltd, Sauflon CL Manufacturing & Trading Kft, Sauflon Pharmaceuticals Ltd., TCC Holdings S.a.r.l., and The Cooper Companies Global Holdings LP.

The Cooper Companies was founded in 1958.

The official website for The Cooper Companies is www.coopercos.com.

The Cooper Companies is headquartered at 6101 Bollinger Canyon Road Suite 500, San Ramon CA, 94583.

The Cooper Companies' mailing address is 6101 Bollinger Canyon Road Suite 500, San Ramon CA, 94583. The medical device company can be reached via phone at 925-460-3600 or via email at [email protected]